Around the world, the markets best-placed to capitalise on the benefits of biosimilars are those with a high-functioning and competitive market, where multiple manufacturers are motivated to participate over the longer term, and where physicians are at the heart of the decision-making process.
Uptake drivers must be introduced to support a functioning and competitive biosimilars market in Australia
Successful biosimilar markets are characterised by the introduction of uptake drivers that encourage physicians to prescribe biosimilars and incentivise patients to accept biosimilars.